Daxor Corporation Common Stock (DXR) is a publicly traded Healthcare sector company. As of May 21, 2026, DXR trades at $11.35 with a market cap of $63.81M and a P/E ratio of 0.00. DXR moved +0.00% today. Year to date, DXR is -21.38%; over the trailing twelve months it is +50.73%. Its 52-week range spans $6.55 to $14.76. Analyst consensus is buy with an average price target of $22.50. Rallies surfaces DXR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for DXR, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $11.35 |
| Market Cap | $63.81M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.03% |
| 52-Week High | $14.76 |
| 52-Week Low | $6.55 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.45M |
| Net Income | $-7.19M |
| Gross Margin | 54.89% |
2 analysts cover DXR: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $22.50.